BeadArray-based solutions for enabling the promise of pharmacogenomics : Applying technologies towards safe and effective medicinesFAN, Jian-Bing; HU, Sean X; CRAUMER, William C et al.BioTechniques. 2005, Vol 39, Num 4, pp 583-588, issn 0736-6205, 6 p.Article

Pharmacogenomics : from bedside to clinical practiceMARSH, Sharon; MCLEOD, Howard L.Human molecular genetics (Print). 2006, Vol 15, issn 0964-6906, R89-R93, NSArticle

Pharmacogenomics in clinical practice and drug developmentHARPER, Andrew R; TOPOL, Eric J.Nature biotechnology (Print). 2012, Vol 30, Num 11, pp 1117-1124, issn 1087-0156, 8 p.Article

Les applications en rhumatologie: en génomiqueDIEUDE, Philippe; GARCHON, Henri-Jean.Revue du rhumatisme (Ed. française). 2011, Vol 78, issn 1169-8330, S178-S181, SUP4Article

PharmacogenomicsMARSH, S.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix24-ix28, SUP9Conference Paper

Pharmacogenomics in clinical trialsLAGERCRANTZ, Jacob.Recent research developments in biophysics and biochemistry vol. 4 - 2004 Part I. Recent research developments in biophysics and biochemistry. 2004, pp 145-173, isbn 81-7736-214-3, 29 p.Book Chapter

Should pharmacogenomic studies be required for new drug approval?RELLING, M. V; HOFFMAN, J. M.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 3, pp 425-428, issn 0009-9236, 4 p.Article

Pharmacogenomics and the future of drug therapyHINES, Ronald N; MCCARVER, D. Gail.The Pediatric clinics of North America. 2006, Vol 53, Num 4, issn 0031-3955, 591-619, vii-viii [31 p.]Article

Médecine individualisée : entre potential et réalitéAMIR-ASLANI, A; BAUCHER, M.-A; SHIRI, G et al.Biofutur (Puteaux). 2009, Num 295, pp 54-56, issn 0294-3506, 3 p.Article

Application of pharmacogenomic strategies to the study of drug-induced birth defectsLEEDER, J. S; MITCHELL, A. A.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 4, pp 595-599, issn 0009-9236, 5 p.Article

The emerging role of pharmacogenomics in biologicsLACANI, E; AMUR, S; MUMMANNENI, P et al.Clinical pharmacology and therapeutics. 2007, Vol 82, Num 4, pp 466-471, issn 0009-9236, 6 p.Article

PharmacogenomicsWONG, Steven H.Clinical chemistry and laboratory medicine. 2007, Vol 45, Num 7, pp 799-842, issn 1434-6621, 43 p.Conference Paper

Glutathione S-transferase omega 1 and omega 2 pharmacogenomicsMUKHERJEE, Baidehi; SALAVAGGIONE, Oreste E; PELLEYMOUNTER, Linda L et al.Drug metabolism and disposition. 2006, Vol 34, Num 7, pp 1237-1246, issn 0090-9556, 10 p.Article

Pharmacogenomic discovery approaches : Will the real genes please stand up?WALGREN, Richard A; MEUCCI, Melissa A; MCLEOD, Howard L et al.Journal of clinical oncology. 2005, Vol 23, Num 29, pp 7342-7349, issn 0732-183X, 8 p.Article

Genome-wide association studies in pharmacogenomicsDALY, Ann K.Nature reviews. Genetics (Print). 2010, Vol 11, Num 4, pp 241-246, issn 1471-0056, 6 p.Article

Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development : Applying technologies towards safe and effective medicinesLI YAN; BECKMAN, Robert A.BioTechniques. 2005, Vol 39, Num 4, pp 565-568, issn 0736-6205, 4 p.Article

Applying Pharmacogenomics in Drug Development: Part IGURWITZ, David.Drug development research. 2004, Vol 62, Num 2, issn 0272-4391, 91 p.Serial Issue

Applying pharmacogenomics in drug development: part IIGURWITZ, David.Drug development research. 2004, Vol 62, Num 3, issn 0272-4391, 136 p.Serial Issue

Pharmacogenomics of adverse drug reactions: implementing personalized medicineWEI, Chun-Yu; MICHAEL LEE, Ming-Ta; CHEN, Yuan-Tsong et al.Human molecular genetics (Print). 2012, Vol 21, Num 1, issn 0964-6906, R58-R65, NS1Article

HapMap, pharmacogenomics, and the goal of personalized prescribingO'SHAUGHNESSY, Kevin M.British journal of clinical pharmacology. 2006, Vol 61, Num 6, pp 783-786, issn 0306-5251, 4 p.Article

Clinically Available Pharmacogenomics TestsFLOCKHART, D. A; SKAAR, T; BERLIN, D. S et al.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 1, pp 109-113, issn 0009-9236, 5 p.Article

Shifting emphasis from pharmacogenomics to theragnosticsOZDEMIR, Vural; WILLIAMS-JONES, Bryn; GLATT, Stephen J et al.Nature biotechnology. 2006, Vol 24, Num 8, pp 942-947, issn 1087-0156, 6 p.Article

Bringing genomics to the bedside: a cost-effective pharmacogenomic test?VEENSTRA, David L.Pharmacogenetics (London). 2004, Vol 14, Num 6, pp 333-334, issn 0960-314X, 2 p.Article

Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie aheadNEBERT, Daniel W; VESELL, Elliot S.European journal of pharmacology. 2004, Vol 500, Num 1-3, pp 267-280, issn 0014-2999, 14 p.Article

Challenges in the Pharmacogenomic Annotation of Whole GenomesALTMAN, R. B; WHIRL-CARRILLO, M; KLEIN, T. E et al.Clinical pharmacology and therapeutics. 2013, Vol 94, Num 2, pp 211-213, issn 0009-9236, 3 p.Article